Back to search
FDAFDA · Food and drugs·Recall number Z-2715-2026

VITEK 2 AST-N447 TEST KIT Product reference 424620

Published July 15, 2026 · Recall initiated: June 4, 2026

Summary

FDA records medical device Class II recall Z-2715-2026, published July 15, 2026 and initiated June 4, 2026. Recalling firm: Biomerieux Inc; Status: Ongoing; Reported quantity: 45,900 cards; Lot: Lot 0853293604 UDI-DI 03573026634551 Product is not registered in the US. OUS only. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Biomerieux Inc
Distributor
International distribution to the countries of Belgium and the Netherlands.
Lot
Lot 0853293604 UDI-DI 03573026634551 Product is not registered in the US. OUS only.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was VITEK 2 AST-N447 TEST KIT Product reference 424620 recalled?

Yes. FDA published recall Z-2715-2026 on July 15, 2026. Reported hazard: Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures.

What should I do if I have this product?

Voluntary: Firm initiated · Letter